NIVEX TRIAL (GECP 1605): Nivolumab in the Real World: Spanish Expanded Access Program Experience in Pretreated Advanced NSCLC Patients
No Thumbnail Available
Identifiers
Date
2018-10-01
Authors
Rodriguez-Abreu, D.
Campillo, J.
Grau, F.
Carcereny, E.
Bernabe, R.
Garcia, Y.
Artal Cortes, A.
Gonzalez Cao, M.
Juan, O.
Garicano, F.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier science inc
Abstract
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
real world, nivolumab, NSCLC